Open Philanthropy recommended a grant of $140,000 over two years to the International Vaccine Institute (IVI) to support the assessment of the safety and efficacy of SchistoShield®, a promising schistosomiasis vaccine candidate. The assessment will be conducted by the Vaccine Against Schistosomiasis in Africa project, which is led by IVI. If safe and effective, the vaccine could be used in both humans and cattle, the latter of which contribute to the spread of the disease.
This falls within Open Philanthropy’s work on scientific research, specifically within its interest in advancing human health and wellbeing.